Company Performance Metrics
- Christopher Rohde: Co-Founder and CTO
- Matt Angel: Co-Founder and CEOPast Role: Ernexa Therapeutics, Chief Executive Officer
Factor Bioscience is building the future of regenerative medicine by targeting and repairing the molecular origins of disease. Factor Bioscience was established to explore new methods for controlling gene expression and cell fate. Their scientists developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent
stem-cell state, a key invention now recognized by several patents. This technology, which enables the production of patient-specific cells for transplantation, has wide-ranging applications in personalized regenerative medicine.
